Evidence supporting secondary prevention strategies.
Published
Journal Article (Review)
Currently 14 million individuals in the United States have coronary disease. Within the next 2 decades, this number is expected to increase to 21 million persons. To minimize the excessive risk of recurrent cardiac events in these people, evidence-based, cost-effective prevention strategies must be developed. This review highlights the evidence supporting commonly used means of secondary prevention and is divided into two major sections: lifestyle modifications and pharmacologic interventions. Lifestyle changes discussed include smoking cessation, especially newer pharmacologic adjuncts; the efficacy of dietary interventions; and current inroads into the treatment of depression in recurrent events. Pharmacologic innovations include reexamination of a role for warfarin; continued advances in the treatment of hyper- and dyslipidemias, new roles for beta-blockade in congestive heart failure, and finally a view of future measures, risk and targets of risk intervention.
Full Text
Duke Authors
Cited Authors
- Blazing, MA; O'Connor, CM
Published Date
- July 1999
Published In
Volume / Issue
- 14 / 4
Start / End Page
- 303 - 309
PubMed ID
- 10448610
Pubmed Central ID
- 10448610
International Standard Serial Number (ISSN)
- 0268-4705
Digital Object Identifier (DOI)
- 10.1097/00001573-199907000-00005
Language
- eng
Conference Location
- United States